相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion
Crescenzo D'Alterio et al.
SEMINARS IN CANCER BIOLOGY (2020)
Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages
Dong Wang et al.
CANCER LETTERS (2020)
New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM
Stefania Scala et al.
VACCINES (2020)
CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p
Xinfeng Yu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule
Chloe Sauzay et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
1906PBasal NK activity and early Treg function inhibition predicts Nivolumab responsiveness in metastatic renal cancer patients (REVOLUTION) trial
S Santagata et al.
ANNALS OF ONCOLOGY (2019)
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
Crescenzo D'Alterio et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity
Irina Druzhkova et al.
CLINICAL COLORECTAL CANCER (2019)
A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination
Agnes Figueras et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Cancer Inflammation and Cytokines
Maria Rosaria Galdiero et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway
Chun-Hui Zheng et al.
CELL BIOLOGY INTERNATIONAL (2018)
High co-expression of the SDF1/CXCR4 axis in hepatocarcinoma cells is regulated by AnnexinA7 in vitro and in vivo
Jingwen Wang et al.
CELL COMMUNICATION AND SIGNALING (2018)
Oxaliplatin and irinotecan induce heterogenous changes in the EMT markers of metastasizing colorectal carcinoma cells
Veronika Skarkova et al.
EXPERIMENTAL CELL RESEARCH (2018)
The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer
Jiayu Liang et al.
SCIENTIFIC REPORTS (2018)
DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells
Kyoung Ah Kang et al.
REDOX BIOLOGY (2018)
New insights into the role of EMT in tumor immune escape
Stephane Terry et al.
MOLECULAR ONCOLOGY (2017)
Common cytotoxic chemotherapeutics induce epithelial-mesenchymal transition (EMT) downstream of ER stress
Parag P. Shah et al.
ONCOTARGET (2017)
Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade
Dirk Zboralski et al.
CANCER IMMUNOLOGY RESEARCH (2017)
The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
Muhammad Zaeem Noman et al.
ONCOIMMUNOLOGY (2017)
CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer
Xinfeng Yu et al.
SCIENTIFIC REPORTS (2017)
Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers
Michal Abraham et al.
CLINICAL CANCER RESEARCH (2017)
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
Milena P. Mak et al.
CLINICAL CANCER RESEARCH (2016)
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion
Raffaela Fontanella et al.
CANCER LETTERS (2016)
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists
Salvatore Di Maro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients
Crescenzo D'Alterio et al.
ONCOIMMUNOLOGY (2016)
HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer
R. Muralidharan et al.
CANCER GENE THERAPY (2015)
Molecular Pathways: Targeting the CXCR4-CXCL12 Axis-Untapped Potential in the Tumor Microenvironment
Stefania Scala
CLINICAL CANCER RESEARCH (2015)
Evidence of CD90+CXCR4+cells as circulating tumor stem cells in hepatocellular carcinoma
Liang Zhu et al.
TUMOR BIOLOGY (2015)
Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer
Qinhong Xu et al.
ONCOTARGET (2015)
Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers
Venkat R. Katkoori et al.
ONCOTARGET (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Downregulation of UHRF1 promotes EMT via inducing CXCR4 in human cancer cells
Yi-Deun Jung et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway
Ting-hua Hu et al.
CANCER LETTERS (2014)
A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients
Crescenzo D'Alterio et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
CXCL12-CXCR4 signaling is required for the maintenance of mouse spermatogonial stem cells
Qi-En Yang et al.
JOURNAL OF CELL SCIENCE (2013)
Tumor metastasis: moving new biological insights into the clinic
Liling Wan et al.
NATURE MEDICINE (2013)
Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
Luigi Portella et al.
PLOS ONE (2013)
CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
Shan-shan Zhang et al.
BMC MEDICINE (2012)
3′-Deoxy-3′-18F-Fluorothymidine PET/CT to Guide Therapy with Epidermal Growth Factor Receptor Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer
Antonella Zannetti et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Development of a Unique Small Molecule Modulator of CXCR4
Zhongxing Liang et al.
PLOS ONE (2012)
Predictors of Cure After Hepatic Resection of Colorectal Liver Metastases: An Analysis of Actual 5- and 10-Year Survivors
Terence C. Chua et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Imaging of αvβ3 Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with αvβ5
Antonella Zannetti et al.
CLINICAL CANCER RESEARCH (2009)
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines
Anthony D. Yang et al.
CLINICAL CANCER RESEARCH (2006)
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients
A Ottaiano et al.
CLINICAL CANCER RESEARCH (2006)
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II study
SR Alberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells
A Ottaiano et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
分享论文
